Impact of Dronedarone Treatment on Healthcare Resource Utilization in Patients with Atrial Fibrillation/Flutter

BACKGROUND: The ATHENA (A Placebo-Controlled, Double-Blind, Parallel Arm Trial to Assess the Efficacy of Dronedarone 400 mg bid for the Prevention of Cardiovascular Hospitalization or Death from Any Cause in Patients with Atrial Fibrillation/Atrial Flutter) trial demonstrated a significant reduction...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Michael H., Lin, Jay, Jhaveri, Mehul, Koren, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961599/
https://www.ncbi.nlm.nih.gov/pubmed/24595638
http://dx.doi.org/10.1007/s12325-014-0108-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961599/
https://www.ncbi.nlm.nih.gov/pubmed/24595638
http://dx.doi.org/10.1007/s12325-014-0108-x

Ejemplares similares